Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): A prospective study

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 6, 2013, Pages 562-569

  Mavinkurve Groothuis, Annelies M C ^a   Marcus, Karen A ^a   Pourier, Milanthy ^a   Loonen, Jacqueline ^a   Feuth, Ton ^a   Hoogerbrugge, Peter M ^a   De Korte, Chris L ^a   Kapusta, Livia ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

ALL; Anthracyclines; Cardiac biomarkers; Early onset cardiotoxicity; Myocardial strain imaging

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; GLUCOSE; IDARUBICIN; MITOXANTRONE; SODIUM CHLORIDE; TROPONIN T;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIAC IMAGING; CARDIOVASCULAR MORTALITY; CHILD; CHILDHOOD LEUKEMIA; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPH; FEMALE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE STRAIN; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MUSCLE STRAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEPSIS; STEM CELL TRANSPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TUMOR LYSIS SYNDROME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL STRAIN ECHOCARDIOGRAPHY; WHOLE BODY RADIATION;

ALL; ANTHRACYCLINES; CARDIAC BIOMARKERS; EARLY-ONSET CARDIOTOXICITY; MYOCARDIAL STRAIN IMAGING;

ADOLESCENT; ANTHRACYCLINES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME; TROPONIN T; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84877934193     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes217     Document Type: Article

References (46)

1. Wouters KA, Kremer LC, Miller TL, Herman EH, Lipshultz SE. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol 2005;131:561-78. (Pubitemid 43899624)
2. Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group Experience. J Clin Oncol 1997;15:1544-52. (Pubitemid 27167391)
3. Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001;19:3163-72. (Pubitemid 32591432)
4. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-15.
5. Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995;332:1738-43.
6. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005;23:2629-36. (Pubitemid 46179451)
7. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;8:1349-53. (Pubitemid 28036901)
8. Horacek JM, Pudul R, Tichy M, Jebavý L, Strasová A, Praus R et al. The use of bio-markers in cardiotoxicity monitoring in patients treated for leukemia. Neoplasma 2005;52:430-34. (Pubitemid 41406693)
9. Auner HW, Tinchon C, Linkesch W, Tiran A, Quehenberger F, Link H et al. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies. Ann Hematol 2003;82:218-22. (Pubitemid 36701012)
10. Cardinale D, Sandri MT, Martinoni A, Tricca A, Civelli M, Lamantia G et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 2000;36:517-22.
11. Suzuki T, Hayashi D, Yamazaki T, Mizuno T, Kanda Y, Komuro I et al. Elevated B-type natriuretic peptide levels after anthracycline administration. Am Heart 1998;136:362-3. (Pubitemid 28368863)
12. Okumura H, Iuchi K, Yoshida T, Nakamura S, Takeshima M, Takamatsu H et al. Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity. Acta Haematol 2000;104:158-63. (Pubitemid 32250128)
13. Bryant J, Picot J, Baxter L, Levitt G, Sullivan I, Clegg A. Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. Eur J Cancer 2007;43:1959-66. (Pubitemid 47299200)
14. Mavinkurve-Groothuis AM, Kapusta L, Nir A, Groot-Loonen J. The role of bio-markers in the early detection of anthracycline-induced cardiotoxicity in children. A review of the literature. Pediatr Hematol Oncol 2008;25:655-64.
15. Ganame J, Claus P, Eyskens B, Uyttebroeck A, Renard M, D'hooge J et al. Acute cardiac functional and morphological changes after Anthracycline infusions in children. Am J Cardiol 2007;99:974-7. (Pubitemid 46483288)
16. Mavinkurve-Groothuis AM, Groot-Loonen J, Marcus KA, Bellersen L, Feuth T, Bökkerink JP et al. Myocardial strain and strain rate in monitoring subclinical heart failure in asymptomatic long-term survivors of childhood cancer. Ultrasound Med Biol 2000;36:1783-91.
17. Tsai HR, Gjesdal O, Wethal T, Haugaa KH, Fosså A, Fosså SD et al. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy. Am J Cardiol 2011;107:472-7.
18. Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ et al. Subclinical anthracycline-and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 2010;96:701-7.
19. Cheung YF, Hong WJ, Chan GC, Wong SJ, Ha SY. Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy. Heart 2010;96:1137-41.
20. Kamps WA, van der Pal-de Bruin KM, Veerman AJP, Fiocco M, Bierings M, Pieters R. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia 2010; 24:309-19.
21. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. Scand J Clin Lab Invest Suppl 1999;230:128-31. (Pubitemid 29279365)
22. Albers S, Mir TS, Haddad M, Läer S. N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and inter-laboratory variability. Clin Chem Lab Med 2006;44:80-5. (Pubitemid 43010651)
23. Korinek J, Wang J, Sengupta PP, Miyazaki C, Kjaergaard J, McMahon E et al. Two-dimensional strain-a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo. J Am Soc Echocardiogr 2005;18:1247-53. (Pubitemid 41821166)
24. Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M et al. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 2004;17:1021-9. (Pubitemid 39273478)
25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. American Society of Echocardiography's Nomenclature and Standards Committee. Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Eur J Echocardiogr 2006;7:79-108.
26. Kampmann C, Wiethoff C, Wenzel A, Stolz G, Betancor M, Wippermann C et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000;83:667-72. (Pubitemid 30345969)
27. Foster BJ, Mackie AS, Mitsnefes M, Ali H, Mamber S, Colan SD. A novel method of expressing left ventricular mass relative to body size in children. Circulation 2008; 117:2769-75. (Pubitemid 351770457)
28. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;15:1527-33. (Pubitemid 27486472)
29. O'Leary PW, Durongpisitkul K, Cordes TM, Bailey KR, Hagler DJ, Tajik J et al. Dia-stolic ventricular function in children: a Doppler echocardiographic study establishing normal values and predictors of increased ventricular end-diastolic pressure. Mayo Clin Proc 1998;73:616-28.
30. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8. (Pubitemid 8066109)
31. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42. (Pubitemid 34262671)
32. Mavinkurve-Groothuis AM, Weijers G, Groot-Loonen J, Pourier M, Feuth T, de Korte CL et al. Interobserver, intraobserver and intrapatient reliability scores of myocardial strain imaging in 2-dimensional echocardiography in patients treated with anthracyclines. Ultrasound Med Biol 2009;35:697-704.
33. Marcus KA, Mavinkurve-Groothuis AM, Barends M, van Dijk A, Feuth T, de Korte C et al. Reference values for myocardial two-dimensional strain echocardi-ography in a healthy pediatric and young adult cohort. J Am Soc Echocardiogr 2011; 24:625-36.
34. Sparano JA, Wolff AC, Brown D. Troponins for predicting cardiotoxicity from cancer therapy. Lancet 2000;356:1947-8.
35. Rammeloo LA, Postma A, Sobotka-Plojhar MA, Bink-Boelkens MT, Berg A, Veerman AJ et al. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. Med Pediatr Oncol 2000; 35:13-9. (Pubitemid 30447819)
36. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T et al. Val-HeFT Investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9. (Pubitemid 47517535)
37. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 2011; 107:1375-80.
38. Mavinkurve-Groothuis AM, Groot-Loonen J, Bellersen L, Pourier MS, Feuth T, Bökkerink PM et al. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines. Pediatr Blood Cancer 2009;52:631-6.
39. Dolci A, Dominici R, Cardinale D, Sandri MT, Panteghine M. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol 2008; 130:688-95.
40. de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL et al. The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 2012;272:55-64.
41. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC et al. Assessment of echo-cardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, Taxanes and Trastuzumab. Circ Cardiovasc Imaging 2012;5:596-603.
42. Greenberg NL, Firstenberg MS, Castro PL, Main M, Travaglini A, Odabashian JA et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation 2002;105:99-105. (Pubitemid 34049149)
43. Nesbitt GC, Mankad S. Strain and strain rate imaging in cardiomyopathy. Echocar-diography 2009;26:337-44.
44. Ferferieva V, Van den Bergh A, Claus P, Jasaityte R, Veulemans P, Pellens M et al. The relative value of strain and strain rate for defining intrinsic myocardial function. Am J Physiol Heart Circ Physiol 2012;30:H188-95.
45. Mavinkurve-Groothuis AM, Groot-Loonen J, Marcus KA, Bellersen L, Feuth T, Bökkerink JP et al. Myocardial strain and strain rate in monitoring subclinical heart failure in asymptomatic long-term survivors of childhood cancer. Ultrasound Med Biol 2010;36:1783-91.
46. Lopez-Andrès N, Rossignol P, Iraqi W, Fay R, Nuée J, Ghio S et al. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. Eur J Heart Fail 2012;14:74-81.